French Artificial Heart Maker Carmat Targets Breakeven in 2027

French artificial heart maker Carmat expects to breakeven in 2027, it said on Monday, as it gradually resumes implants and faces strong demand in Europe ahead of its commercial launch in the United States.
Reuters Health Information

source https://www.medscape.com/viewarticle/987346?src=rss